C. David Pauza is a Chief Science Officer with extensive experience in antiviral drug development. Pauza has held various leadership roles in prestigious organizations such as University of Maryland, Marlene and Stewart Greenebaum Cancer Center, and The National Institutes of Health. Pauza's educational background includes a PhD in Molecular Biology from the University of California, Berkeley.
Org chart
Teams
Offices
This person is not in any offices
V
Viriom
Viriom is a commercial and late development stage biotech company developing novel therapies and prevention treatments against HIV and hepatitis B virus (HBV).
